Search

everythinglearnresearchcommunity

for

Search:↓

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Eflornithine cream effectively reduces facial hair in women with hirsutism.

Obesity is strongly linked to the severity of hirsutism in women.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Certain factors can trigger hormonal imbalances and cyst formation, leading to Polycystic Ovarian Syndrome (PCOS).

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

PCOS increases sexual pain distress in infertile women.

Topical cream eflornithine 11.5% can slow hair growth and may help reduce hair removal frequency.

Cortisone and cortisol levels in pregnant women’s hair increase as labor approaches, indicating higher stress.

Many acne patients have high androgen levels, which may lead to PCOD, but treatments like oral contraceptives and antiandrogens can help.

Hirsutism is managed by assessing testosterone levels and using oral contraceptives, with ethical considerations on treatment access.

Early diagnosis and treatment of PCOS can prevent complications and improve symptoms.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Balancing hormones is crucial for women's health and may require hormone therapy.

PCOS symptoms vary by age, affecting diagnosis and treatment.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Adult acne is often mild and common on the cheek, with a low prevalence of PCOS in female patients, but more severe acne and skin damage in those with PCOS.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

A postmenopausal woman's excess male hormone symptoms were caused by a rare adrenal gland tissue in her ovary.

Women with acne and PCOS should be checked for insulin resistance and related symptoms.

Hirsutism in females is complex, often linked to tumors, and requires more research for better treatment.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.